Emcure Pharmaceuticals Announcements
Update on Re-appointment of Dr. Mukund Gurjar as a Whole-time Director and Appointment of Secretarial Auditor of the Company.
29 Aug, 2025 | 08:28pm • Source: BSE
Voting Results of the 44th Annual General Meeting of the Company along-with consolidated Report of the Scrutinizer.
29 Aug, 2025 | 08:20pm • Source: BSE
Proceedings of the 44th Annual General Meeting of the Members of the Company
28 Aug, 2025 | 05:50pm • Source: BSE
Transcript of Earnings Call - Q1 FY26 held on August 07, 2025 at 3.30 pm (IST)
13 Aug, 2025 | 03:56pm • Source: BSE
Newspaper Publication of Unaudited Financial Results of the Company for the quarter ended June 30, 2025
08 Aug, 2025 | 03:23pm • Source: BSE
Intimation under Regulation 30 and 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, about dispatch of letters to the Members whose e-mail...
07 Aug, 2025 | 09:50pm • Source: BSE
Audio recording of Earnings Call - Q1 FY26
07 Aug, 2025 | 09:31pm • Source: BSE
Outcome of the Board Meeting held on August 07, 2025 to approve the Unaudited Financial Results (Consolidated and Standalone) for the quarter ended June 30,...
07 Aug, 2025 | 01:42pm • Source: BSE
Outcome of Board Meeting held on August 07, 2025 to approve the Unaudited Financial Results (Consolidated and Standalone) for the quarter ended June 30, 2025
07 Aug, 2025 | 01:33pm • Source: BSE
Intimation of the 44th AGM and Record date for Final Dividend for the financial year ended March 31, 2025.
01 Aug, 2025 | 06:58pm • Source: BSE
Intimation for Earnings Call - Q1 FY26
28 Jul, 2025 | 05:56pm • Source: BSE
Emcure Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2025 ,inter alia, to consider and...
28 Jul, 2025 | 05:47pm • Source: BSE
Press Release titled - "Emcure Pharmaceuticals Ltd. and Sanofi India Limited Announce Exclusive Distribution Partnership to Broaden Reach of Sanofi''s Oral Anti-diabetic Drugs"
16 Jul, 2025 | 05:20pm • Source: BSE
Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Appointment of Mr. R.S. Vasan as President - India Business and Senior Management Personnel...
14 Jul, 2025 | 01:12pm • Source: BSE
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - US FDA inspection at our manufacturing facility (Oncology) located at...
09 Jul, 2025 | 05:22pm • Source: BSE
Confirmation under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2025
09 Jul, 2025 | 04:09pm • Source: BSE
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Incorporation of a Wholly-owned Subsidiary of the Company with the...
04 Jul, 2025 | 02:51pm • Source: BSE
Intimation of closure of Trading Window
25 Jun, 2025 | 07:53pm • Source: BSE
Intimation under Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- Submission of application for seeking re-classification from the " Promoter and...
25 Jun, 2025 | 07:47pm • Source: BSE
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the disclosure regarding an Order received from the...
25 Jun, 2025 | 05:55pm • Source: BSE